Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine

David Fitz-Patrick

East-West Medical Research Institute, Honolulu

Donald S. McVinnie

Vaccine Research and Development, Pfizer, Marlow, United Kingdom

Lisa A. Jackson

Kaiser Permanente Washington Health Research Institute, Seattle

Graham Crowther

Vaccine Research and Development, Pfizer, Marlow, United Kingdom

Anita Geevarughese

Vaccine Research and Development, Pfizer, Pearl River, NY

Kevin D. Cannon

PMG Research of Wilmington, Wilmington, NC

Lazaro M. Garcia

Entrust Clinical Research, Miami

Yanely Pineiro Puebla

Palm Springs Community Health Center, Miami Lakes, FL

Zhuobiao Yi

Vaccine Research and Development, Pfizer, Collegeville, PA

Luke Cunliffe

Vaccine Research and Development, Pfizer, Pearl River, NY

Alok Maniar

Vaccine Research and Development, Pfizer, Pearl River, NY

Agnieszka M. Zareba

Vaccine Research and Development, Pfizer, Collegeville, PA

Claudia Ana Ianos

Worldwide Safety, Pfizer, New York

Emily Gomme

Vaccine Research and Development, Pfizer, Pearl River, NY

Kenneth Koury

Vaccine Research and Development, Pfizer, Pearl River, NY

Pirada Suphaphiphat Allen

Vaccine Research and Development, Pfizer, Pearl River, NY

Annaliesa S. Anderson

Vaccine Research and Development, Pfizer, Pearl River, NY

Alejandra Gurtman

Vaccine Research and Development, Pfizer, Pearl River, NY

Kelly Lindert

Vaccine Research and Development, Pfizer, Cambridge, MA